Share

    


Home / Search Results

Search Results

You searched for:

Led by the Colorado Pharmacists Society and the sponsorship of Colorado state senators Faith Winter and Joann Ginal and Representatives Dylan Roberts and David Ortiz, Senate Bill 94 was signed into law June 24, 2021 by Colorado Governor Jared Polis, greatly expanding the scope of practice for state pharmacy professionals. Read how the expansion of collaborative practice agreements under the new legislation …
ACCC worked with members of the ACCC Financial Advocacy Network to provide guidance on how to help patients access much-need financial assistance regardless of their insurance status. Here, a financial navigator at Kettering Cancer Care in Kettering, Ohio, discusses how to help patients afford their cancer care if they are uninsured or underinsured and if they are eligible to participate in their …
Beginning January 2022, CMS will be required to cover for Medicaid patients the routine costs associated with participating in clinical trials. Learn what states and provider organizations can do to leverage this mandate to address barriers to care in the community and reduce inequities in clinical trial participation.
“State legislators play a significant role when it comes to health insurance oversight, regulation, and innovation.” – National Council of State Legislatures. Learn how oncology state societies are advocating for greater access to fertility preservation services for patients with cancer, including insurance coverage for these services.
On June 1, 2021, the Governor of Louisiana signed legislation that banned “white bagging” in the state, ensuring that health insurers cannot refuse to pay for approved physician-administered drugs and related services to covered patients. It is the first such law in the United States.
In March, the Wisconsin legislature passed the 2021 Wisconsin Act 9 with overwhelming bipartisan support. Enactment of this PBM reform legislation establishes, for the first time, PBM oversight in Wisconsin.
No one disputes the need to rein in U.S. healthcare costs. However, for patients with cancer and the providers who care for them, the increasing burden of prior authorizations, step therapy requirements, and the lack of transparency regarding certain PBM business practices add on costs. Find out what advocates in Tennessee are doing to enact reform at the state level.